**Core Concept**
Myeloma, also known as multiple myeloma, is a type of blood cancer characterized by the proliferation of malignant plasma cells in the bone marrow. The disease can lead to bone destruction, kidney damage, and anemia due to the suppression of normal hematopoiesis.

**Why the Correct Answer is Right**
The correct answer to this question will highlight a characteristic feature of myeloma. Myeloma is a malignancy of plasma cells, which are responsible for producing antibodies. The disease often presents with hypercalcemia due to bone destruction, anemia, and renal insufficiency. The pathophysiology of myeloma involves the uncontrolled proliferation of malignant plasma cells, which can secrete cytokines and other factors that promote bone resorption and suppress normal hematopoiesis.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because myeloma is not typically associated with the presence of a characteristic "blastic" or immature appearance of plasma cells, unlike lymphoma.

**Option B:** This option is incorrect because while anemia is a common feature of myeloma, it is not the most distinctive or defining characteristic of the disease.

**Option C:** This option is incorrect because hypercalcemia is a common complication of myeloma, but it is not the only possible presentation of the disease.

**Option D:** This option is incorrect because renal insufficiency is a common feature of myeloma, but it is not the most distinctive or defining characteristic of the disease.

**Clinical Pearl / High-Yield Fact**
One important clinical correlation to remember is that myeloma can present with a variety of symptoms, including bone pain, fatigue, and recurrent infections, but it is often diagnosed incidentally on routine laboratory tests, such as a complete blood count or serum protein electrophoresis.

**Correct Answer:** None of the above